Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Antiviral Therapy|February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumaratePeter L Havens, Rohan Hazra, Charles B Stephensen, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
AIDS (London, England)|April 8, 2021
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of ageChristine E MacBrayne, Richard M Rutstein, Andrew A Wiznia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2025
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-CArthur Y Kim, Minhee Kang, Triin Umbleja, et al.
AIDS Research and Human Retroviruses|August 17, 2016
Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady StateSharon M Seifert, Xinhui Chen, Amie L Meditz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2024
Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in Dried Blood Spots for Persons With HIV Receiving Tenofovir Alafenamide and Emtricitabine-Based Antiretroviral Therapy (QUANTI-TAF)Ryan P Coyle, Mary Morrow, Sarah C Mann, et al.
The European Respiratory Journal|December 18, 2025
Efficacy of isoniazid in pediatric tuberculosis: an individual participant data meta-analysisAgathe Béranger, Belén P Solans, Ryo Miyakawa, et al.
The Lancet. HIV|August 4, 2023
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation studyKristina M Brooks, Jennifer J Kiser, Lauren Ziemba, et al.
Pageof 10